Results 231 to 240 of about 1,140,223 (331)

Construction of a risk and prognostic model for migrasome-associated lncRNAs in renal cell carcinoma. [PDF]

Sci Rep
Zhao L, Geng F, Ji X, Geng C, Liu T.
europepmc   +1 more source

Initial appearance of renal cell carcinoma as a metastatic tumor of the olecranon.

, 1988
Yoshiaki Kuribayashi, Masateru Ijichi, Yasuyuki Kobayashi, Nario Ihara, Shinichi Mishima, Masakatsu Setojima   +5 more
openalex   +2 more sources

Therapeutic targeting of myeloid cells in liver fibrosis: Mechanisms and clinical prospects

Animal Models and Experimental Medicine, EarlyView.
This review systematically summarizes the origin, recruitment, and differentiation regulation mechanisms of myeloid cells in driving hepatic fibrosis progression. By targeting these three critical phases, potential therapeutic strategies for liver fibrosis can be explored.
Yue Wang, Yiming Liu, Dan Chen, Leiming Liu, Leimin Sun, Lingling Zhang   +5 more
wiley   +1 more source

Early Clinical Histotripsy Treatment of Renal Cell Carcinoma. [PDF]

Cardiovasc Intervent Radiol
Wah TM, Abdel-Hadi O, Brandon J, Bhambra B, Glencross H, Occidental J, Stones JM, Vasudev N, Bhattarai S, Cartledge J.   +9 more
europepmc   +1 more source

EXPERIENCE OF THE PARENCHYMA SAVING PROCEDURE IN THE SURGICAL MANAGEMENT OF RENAL CELL CARCINOMA

, 1989
Masaki Togashi, Tatsuya Mori, Satoshi Nagamori, Bunshiro Saitoh, Hajime Morita, Toshimori Seki, Toshiaki Gotoh, Katsuya Nonomura, Tomohiko Koyanagi   +8 more
openalex   +2 more sources

Advances on Albumin‐Based Carriers for Anticancer Drug Delivery

Advanced NanoBiomed Research, EarlyView.
This study systematically classifies the drug delivery modes of albumin by examining the characteristics of its surface‐active groups and internal binding sites. It provides an in‐depth analysis of various drug delivery strategies and their corresponding targeting mechanisms.
Ruoli Zhou, Rongbin Zhong, Zhonghui Luo, Hua Wei, Cui‐Yun Yu   +4 more
wiley   +1 more source

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Journal of Clinical Oncology, 2009
R. Motzer, Thomas E. Hutson, P. Tomczak, M. Michaelson, R. Bukowski, S. Oudard, S. Négrier, C. Szczylik, R. Pili, G. Bjarnason, X. Garcia-Del-Muro, J. Sosman, E. Solska, G. Wilding, John A Thompson, Sindy T. Kim, I. Chen, Xin Huang, R. Figlin   +18 more
semanticscholar   +1 more source

Pembrolizumab-Induced Hypophysitis in the Setting of Renal Cell Carcinoma. [PDF]

Cureus
Ogbodu K, Sharda M, Vanani NB, Jha P.
europepmc   +1 more source

ACCURACY OF COMPUTED TOMOGRAPHY IN THE STAGING OF RENAL CELL CARCINOMA

, 1989
Fujio Masuda, Hirofumi Kurauchi, Keiichiro Imanaka, Motoshi Kawahara, Hiroshi Nakajo, Toyohei Machida   +5 more
openalex   +2 more sources

Engineered Hydrogels Revolutionize Locoregional Cancer Immunotherapy

Advanced NanoBiomed Research, EarlyView.
This review systematically summarizes the latest research progress on injectable hydrogels in cancer immunotherapy, highlighting their unique advantages in precise immune activation, local drug‐controlled release, and immune microenvironment remodeling. These features provide innovative solutions to overcome the bottlenecks of systemic side effects and
Jiyong Wei, Chunliu Huang, Zenghua Zhou, Yanni Lan   +3 more
wiley   +1 more source